• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Advenzymes Share Price

    Advanced Enzyme Technologies Share PriceAdvanced Enzyme Technologies

    Small Cap 5.4k Result
    ₹353.35
    0.15 (0.04%)
    As on 09 December, 2023 | 06:45 BSE: 540025 NSE: ADVENZYMESISIN: INE837H01020

    Advanced Enzyme Technologies Performance

    Day Range

    • Low 348.10
    • High 358.45
    ₹ 353.35

    52 Week Range

    • Low 225.00
    • High 368.00
    ₹ 353.35
    • Open Price354.70
    • Previous Close353.20
    • Volume437598

    Start SIP in Advanced Enzyme Technologies

    Start SIP

    Advanced Enzyme Technologies Share Price

    • Over 1 Month 6.03%
    • Over 3 Month 9.14%
    • Over 6 Month 27.86%
    • Over 1 Year 12.46%

    Advanced Enzyme Technologies Key Statistics

    P/E Ratio 31.7
    PEG Ratio 1.1
    Market Cap Cr 3,951
    Price to Book Ratio 3.1
    EPS 5
    Dividend 1.4
    Relative Strength Index 64.82
    Money Flow Index 86.18
    MACD Signal 3.92
    Average True Range 13.24

    Advanced Enzyme Technologies Investment Rating

    • Master Rating:

    • Advanced Enzyme Techs. has an operating revenue of Rs. 585.94 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 26% is great, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 19% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 46 which is a POOR score indicating inconsistency in earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 148 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Advanced Enzyme Technologies Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 97858380777271
    Operating Expenses Qtr Cr 70615958586155
    Operating Profit Qtr Cr 27252321191115
    Depreciation Qtr Cr 3333323
    Interest Qtr Cr 0000000
    Tax Qtr Cr 6666524
    Net Profit Qtr Cr 1867171714814
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 321282
    Operating Expenses Annual Cr 237200
    Operating Profit Annual in Cr 7573
    Depreciation Cr 1010
    Interest Annual Cr 00
    Tax Annual Cr 1918
    Net Profit Annual Cr 5655
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 5037
    Cash from Investing Activity Annual Cr -42-14
    Cash from Financing Annual Activity Cr -12-11
    Net Cash Flow Annual Cr -412
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 525480
    Fixed Assets Annual Cr 154141
    Total Non Current Assets Annual Cr 387353
    Total Current Assets Annual Cr 189177
    Total Assets Annual Cr 576530
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 4743
    ROE Annual % 1111
    ROCE Annual % 1415
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2730
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 158147139142139121132
    Operating Expenses Qtr Cr 10710395100999091
    Operating Profit Qtr Cr 51444442403140
    Depreciation Qtr Cr 9989999
    Interest Qtr Cr 1111111
    Tax Qtr Cr 13121013869
    Net Profit Qtr Cr 34293229261824
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 566536
    Operating Expenses Annual Cr 384328
    Operating Profit Annual in Cr 156201
    Depreciation Cr 3535
    Interest Annual Cr 22
    Tax Annual Cr 3747
    Net Profit Annual Cr 106120
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 140122
    Cash from Investing Activity Annual Cr -298-25
    Cash from Financing Annual Activity Cr -26-27
    Net Cash Flow Annual Cr -18470
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 1,2351,089
    Fixed Assets Annual Cr 350338
    Total Non Current Assets Annual Cr 700663
    Total Current Assets Annual Cr 722604
    Total Assets Annual Cr 1,4221,268
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 115102
    ROE Annual % 911
    ROCE Annual % 1114
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3439
    Invest in Advanced Enzyme Technologies

    Advanced Enzyme Technologies Technicals

    EMA & SMA

    Current Price
    ₹353.35
    0.15 (0.04%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹333.32
    • 50 Day
    • ₹326.24
    • 100 Day
    • ₹318.06
    • 200 Day
    • ₹306.65
    • 20 Day
    • ₹330.58
    • 50 Day
    • ₹324.61
    • 100 Day
    • ₹323.06
    • 200 Day
    • ₹295.53

    Advanced Enzyme Technologies Resistance and Support

    PIVOT
    ₹353.3
    Resistance
    First Resistance 358.50
    Second Resistance 363.65
    Third Resistance 368.85
    RSI 64.82
    MFI 86.18
    MACD Single Line 3.92
    MACD 7.00
    Support
    First Resistance 348.15
    Second Resistance 342.95
    Third Resistance 337.80

    Advanced Enzyme Technologies Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 498,355 22,560,531 45.27
    Week 1,354,876 48,734,883 35.97
    1 Month 524,218 21,052,576 40.16
    6 Month 330,087 16,705,720 50.61

    Advanced Enzyme Technologies Result Highlights

    Advanced Enzyme Technologies Synopsis

    NSE-Chemicals-Specialty

    Advanced Enzyme Tech is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 311.53 Cr. and Equity Capital is Rs. 22.37 Cr. for the Year ended 31/03/2023. Advanced Enzyme Technologies Ltd. is a Public Limited Listed company incorporated on 15/03/1989 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1989PLC051018 and registration number is 051018.
    Market Cap 3,951
    Sales 344
    Shares in Float 6.04
    No of funds 86
    Yield 0.28
    Book Value 7.52
    U/D Vol ratio 1.9
    LTDebt / Equity
    Alpha
    Beta 0.97

    Advanced Enzyme Technologies

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 45.92%46.52%49.87%49.87%
    Mutual Funds 5.84%7.08%5.29%5.25%
    Foreign Portfolio Investors 22.27%21.89%21.86%21.74%
    Individual Investors 15.28%14.23%13.28%13.42%
    Others 10.69%10.28%9.7%9.72%

    Advanced Enzyme Technologies Management

    Name Designation
    Mr. Vasant Rathi Non Executive Chairman
    Mr. Mukund M Kabra Whole Time Director
    Ms. Rasika Rathi Non Executive Director
    Dr. Sunny Sharma Non Executive Director
    Mr. Kedar Jagdish Desai Independent Director
    Mr. Pramod Kasat Independent Director
    Ms. Vandana Tilak Independent Director
    Mr. Vinodkumar Jajoo Independent Director
    Ms. Rajshree Patel Independent Director
    Mr. Nitin Desmukh Independent Director

    Advanced Enzyme Technologies Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Advanced Enzyme Technologies Corporate Action

    Date Purpose Remarks
    2023-11-07 Quarterly Results
    2023-08-12 Quarterly Results
    2023-05-13 Audited Results & Dividend
    2023-02-11 Quarterly Results
    2022-11-11 Quarterly Results
    Date Purpose Remarks
    2023-08-05 FINAL Rs.1.00 per share(50%)Final Dividend
    2023-05-20 INTERIM Rs.4.00 per share(200%)Interim Dividend
    2022-08-12 FINAL Rs.1.00 per share(50%)Final Dividend
    2021-09-01 FINAL Rs.0.90 per share(45%)Final Dividend

    Advanced Enzyme Technologies MF Shareholding

    Name Amount(cr)
    ICICI Prudential Value Discovery Fund Growth 32,494
    ICICI Prudential Equity & Debt Fund Growth 26,183
    HDFC Small Cap Fund Growth 25,409
    HDFC Multi Cap Fund Regular Growth 10,000
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3,271

    Advanced Enzyme Technologies FAQs

    What is Share Price of Advanced Enzyme Technologies ?

    Advanced Enzyme Technologies share price is ₹353 As on 09 December, 2023 | 06:31

    What is the Market Cap of Advanced Enzyme Technologies ?

    The Market Cap of Advanced Enzyme Technologies is ₹3951.3 Cr As on 09 December, 2023 | 06:31

    What is the P/E ratio of Advanced Enzyme Technologies ?

    The P/E ratio of Advanced Enzyme Technologies is 31.7 As on 09 December, 2023 | 06:31

    What is the PB ratio of Advanced Enzyme Technologies ?

    The PB ratio of Advanced Enzyme Technologies is 3.1 As on 09 December, 2023 | 06:31

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.